has sponsored live events, journal education, and internet-based CME activities and has awarded more than 80,000 hours of CME credit.Online First from The Oncologist
- Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma
- Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1‐2N0M0, Estrogen Receptor‐Positive, Human Epidermal Growth Receptor 2‐Negative Invasive Breast Cancer: A…
- U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission
- Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral
- Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists
Clinical Trials Results from The Oncologist
- Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study [CLINICAL TRIAL RESULTS]
- A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer [CLINICAL TRIAL RESULTS]
- An Open-Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non-Small Cell Lung Cancer [CLINICAL TRIAL RESULTS]
- Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors [CLINICAL TRIAL RESULTS]
- First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone Disease [CLINICAL TRIAL RESULTS]